EARNEST Partners’s Allergan plc AGN Stock Holding History

EARNEST Partners’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-161	Closed	-$29K	–	1215
2020 Q1	$29K	Hold	161	–	–	﹤0.01%	341
2019 Q4	$31K	Hold	161	–	–	﹤0.01%	375
2019 Q3	$27K	Hold	161	–	–	﹤0.01%	385
2019 Q2	$27K	Hold	161	–	–	﹤0.01%	395
2019 Q1	$24K	Hold	161	–	–	﹤0.01%	411
2018 Q4	$22K	Hold	161	–	–	﹤0.01%	410
2018 Q3	$31K	Hold	161	–	–	﹤0.01%	363
2018 Q2	$27K	Hold	161	–	–	﹤0.01%	387
2018 Q1	$27K	Hold	161	–	–	﹤0.01%	383
2017 Q4	$26K	Buy	+161	New	+$28.9K	﹤0.01%	380
2017 Q1	–	Sell	-186	Closed	-$39K	–	1048
2016 Q4	$39K	Buy	+186	New	+$38.5K	﹤0.01%	308

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

EARNEST Partners's AGN Position: Q2 2020 in Review

EARNEST Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 161 shares — an estimated $29K sold.

EARNEST Partners first reported a position in AGN in Q4 2016 and held it in 11 quarters. The position peaked at $39K in Q4 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

EARNEST Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
EARNEST Partners sold 161 Allergan plc shares in Q2 2020, an estimated $29K.
EARNEST Partners first reported a position in Allergan plc in Q4 2016 and held it in 11 quarters.
EARNEST Partners's Allergan plc position peaked at $39K in Q4 2016.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on EARNEST Partners's 13F filing for Q2 2020, filed 13 Aug 2020.